s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, March 8, 2021
Accession number
0001493152-21-005526
Documents
form8-k.htm
425
ex99-1.htm
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header